β1 integrin cross-linking inhibits CD16-induced phospholipase D and secretory phospholipase A2 activity and granule exocytosis in human NK cells: Role of phospholipase D in CD16-triggered degranulation

Michele Milella, Angela Gismondi, Paola Roncaioli, Gabriella Palmieri, Stefania Morrone, Mario Piccoli, Luigi Frati, Maria Grazia Cifone, Angela Santoni

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Recent data indicate that integrin-generated signals can modulate different receptor-stimulated cell functions in both a positive (costimulation) and a negative (inhibition) fashion. Here we investigated the ability of β1 integrins, namely α4β1 and α5β1 fibronectin receptors, to modulate CD16-triggered phospholipase activation in human NK cells, β1 integrin simultaneous crosslinking selectively inhibited CD16- induced phospholipase D (PLD) activation, without affecting either phosphatidylinositol-phospholipase C or cytosolic phospholipase A2 (PLA2) enzymatic activity. CD16-induced secretory PLA2 (sPLA2) protein release as well as its enzymatic activity in both cell-associated and soluble forms were also found to be inhibited upon β1 integrin coengagement. The similar effects exerted by specific PLD pharmacological inhibitors (2,3- diphosphoglycerate, ethanol) suggest that in our experimental system, sPLA2 secretion and activation are under the control of a PLD-dependent pathway. By using pharmacological inhibitors (2,3-diphosphoglycerate, wortmannin, ethanol) we also demonstrated that PLD activation is an important step in the CD16-triggered signaling cascade that leads to NK cytotoxic granule exocytosis. Consistent with these findings, fibronectin receptor engagement, by either mAbs or natural ligands, resulted in a selective inhibition of CD16-triggered, but not of PMA/ionomycin-induced, degranulation that was reversed by the exogenous addition of purified PLD from Streptomyces chromofuscus.

Original languageEnglish
Pages (from-to)2064-2072
Number of pages9
JournalJournal of Immunology
Volume162
Issue number4
Publication statusPublished - Feb 15 1999

Fingerprint

Secretory Phospholipase A2
Phospholipase D
Exocytosis
Integrins
Natural Killer Cells
2,3-Diphosphoglycerate
Ethanol
Fibronectin Receptors
Integrin alpha5beta1
Pharmacology
Cytosolic Phospholipases A2
Ionomycin
Phospholipases
Streptomyces
Type C Phospholipases
Phosphatidylinositols
Ligands
Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

β1 integrin cross-linking inhibits CD16-induced phospholipase D and secretory phospholipase A2 activity and granule exocytosis in human NK cells : Role of phospholipase D in CD16-triggered degranulation. / Milella, Michele; Gismondi, Angela; Roncaioli, Paola; Palmieri, Gabriella; Morrone, Stefania; Piccoli, Mario; Frati, Luigi; Cifone, Maria Grazia; Santoni, Angela.

In: Journal of Immunology, Vol. 162, No. 4, 15.02.1999, p. 2064-2072.

Research output: Contribution to journalArticle

Milella, Michele ; Gismondi, Angela ; Roncaioli, Paola ; Palmieri, Gabriella ; Morrone, Stefania ; Piccoli, Mario ; Frati, Luigi ; Cifone, Maria Grazia ; Santoni, Angela. / β1 integrin cross-linking inhibits CD16-induced phospholipase D and secretory phospholipase A2 activity and granule exocytosis in human NK cells : Role of phospholipase D in CD16-triggered degranulation. In: Journal of Immunology. 1999 ; Vol. 162, No. 4. pp. 2064-2072.
@article{0fc9797f8d5d4b0ab39f36309b54ae42,
title = "β1 integrin cross-linking inhibits CD16-induced phospholipase D and secretory phospholipase A2 activity and granule exocytosis in human NK cells: Role of phospholipase D in CD16-triggered degranulation",
abstract = "Recent data indicate that integrin-generated signals can modulate different receptor-stimulated cell functions in both a positive (costimulation) and a negative (inhibition) fashion. Here we investigated the ability of β1 integrins, namely α4β1 and α5β1 fibronectin receptors, to modulate CD16-triggered phospholipase activation in human NK cells, β1 integrin simultaneous crosslinking selectively inhibited CD16- induced phospholipase D (PLD) activation, without affecting either phosphatidylinositol-phospholipase C or cytosolic phospholipase A2 (PLA2) enzymatic activity. CD16-induced secretory PLA2 (sPLA2) protein release as well as its enzymatic activity in both cell-associated and soluble forms were also found to be inhibited upon β1 integrin coengagement. The similar effects exerted by specific PLD pharmacological inhibitors (2,3- diphosphoglycerate, ethanol) suggest that in our experimental system, sPLA2 secretion and activation are under the control of a PLD-dependent pathway. By using pharmacological inhibitors (2,3-diphosphoglycerate, wortmannin, ethanol) we also demonstrated that PLD activation is an important step in the CD16-triggered signaling cascade that leads to NK cytotoxic granule exocytosis. Consistent with these findings, fibronectin receptor engagement, by either mAbs or natural ligands, resulted in a selective inhibition of CD16-triggered, but not of PMA/ionomycin-induced, degranulation that was reversed by the exogenous addition of purified PLD from Streptomyces chromofuscus.",
author = "Michele Milella and Angela Gismondi and Paola Roncaioli and Gabriella Palmieri and Stefania Morrone and Mario Piccoli and Luigi Frati and Cifone, {Maria Grazia} and Angela Santoni",
year = "1999",
month = "2",
day = "15",
language = "English",
volume = "162",
pages = "2064--2072",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - β1 integrin cross-linking inhibits CD16-induced phospholipase D and secretory phospholipase A2 activity and granule exocytosis in human NK cells

T2 - Role of phospholipase D in CD16-triggered degranulation

AU - Milella, Michele

AU - Gismondi, Angela

AU - Roncaioli, Paola

AU - Palmieri, Gabriella

AU - Morrone, Stefania

AU - Piccoli, Mario

AU - Frati, Luigi

AU - Cifone, Maria Grazia

AU - Santoni, Angela

PY - 1999/2/15

Y1 - 1999/2/15

N2 - Recent data indicate that integrin-generated signals can modulate different receptor-stimulated cell functions in both a positive (costimulation) and a negative (inhibition) fashion. Here we investigated the ability of β1 integrins, namely α4β1 and α5β1 fibronectin receptors, to modulate CD16-triggered phospholipase activation in human NK cells, β1 integrin simultaneous crosslinking selectively inhibited CD16- induced phospholipase D (PLD) activation, without affecting either phosphatidylinositol-phospholipase C or cytosolic phospholipase A2 (PLA2) enzymatic activity. CD16-induced secretory PLA2 (sPLA2) protein release as well as its enzymatic activity in both cell-associated and soluble forms were also found to be inhibited upon β1 integrin coengagement. The similar effects exerted by specific PLD pharmacological inhibitors (2,3- diphosphoglycerate, ethanol) suggest that in our experimental system, sPLA2 secretion and activation are under the control of a PLD-dependent pathway. By using pharmacological inhibitors (2,3-diphosphoglycerate, wortmannin, ethanol) we also demonstrated that PLD activation is an important step in the CD16-triggered signaling cascade that leads to NK cytotoxic granule exocytosis. Consistent with these findings, fibronectin receptor engagement, by either mAbs or natural ligands, resulted in a selective inhibition of CD16-triggered, but not of PMA/ionomycin-induced, degranulation that was reversed by the exogenous addition of purified PLD from Streptomyces chromofuscus.

AB - Recent data indicate that integrin-generated signals can modulate different receptor-stimulated cell functions in both a positive (costimulation) and a negative (inhibition) fashion. Here we investigated the ability of β1 integrins, namely α4β1 and α5β1 fibronectin receptors, to modulate CD16-triggered phospholipase activation in human NK cells, β1 integrin simultaneous crosslinking selectively inhibited CD16- induced phospholipase D (PLD) activation, without affecting either phosphatidylinositol-phospholipase C or cytosolic phospholipase A2 (PLA2) enzymatic activity. CD16-induced secretory PLA2 (sPLA2) protein release as well as its enzymatic activity in both cell-associated and soluble forms were also found to be inhibited upon β1 integrin coengagement. The similar effects exerted by specific PLD pharmacological inhibitors (2,3- diphosphoglycerate, ethanol) suggest that in our experimental system, sPLA2 secretion and activation are under the control of a PLD-dependent pathway. By using pharmacological inhibitors (2,3-diphosphoglycerate, wortmannin, ethanol) we also demonstrated that PLD activation is an important step in the CD16-triggered signaling cascade that leads to NK cytotoxic granule exocytosis. Consistent with these findings, fibronectin receptor engagement, by either mAbs or natural ligands, resulted in a selective inhibition of CD16-triggered, but not of PMA/ionomycin-induced, degranulation that was reversed by the exogenous addition of purified PLD from Streptomyces chromofuscus.

UR - http://www.scopus.com/inward/record.url?scp=0033558277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033558277&partnerID=8YFLogxK

M3 - Article

C2 - 9973479

AN - SCOPUS:0033558277

VL - 162

SP - 2064

EP - 2072

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -